Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
REGN · against 38 other Healthcare companies of similar size
Ranked #4 of 39 · scores higher than 92% of peers · safety percentile 77
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)3 peers with a safety percentile of 70–79, including REGN · Click a bar to see the companies
Mainly thanks to its beta and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | REGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 34 reported | 0.09× | 0.59× | 88% | 33% | |
| BetaLower is better · 38 reported | 0.19 | 0.54 | 84% | 33% | |
| Current ratioHigher is better · 37 reported | 3.33× | 1.38× | 89% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 56.7B USD | 85 | 79 | |
| 2 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 3 | 4.25T INR (≈$51.0B) | 81 | 70 | |
| 4 | 100.2B USD | 77 | 68 | |
| 5 | 11.26T JPY (≈$76.6B) | 74 | 72 | |
| 6 | 134.5B USD | 72 | 70 | |
| 7 | 54.9B USD | 68 | 59 | |
| 8 | 534.1B HKD (≈$68.4B) | 58 | 75 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score